Blueprint Medicines Corporation
At a glance
EmployeesNot reported
In business sinceNot reported
HeadquartersCambridge, MA
US patents59
SAM.gov UEIW42KVS8X5BV9
CAGE code6NX60
Incorporated inDE
LEI5299004CC60O9T5HVM83
Supplier designations
For Profit OrganizationManufacturer of Goods
Self-certified by the company in its SAM.gov registration
Patents
59 US patents granted 2014–2025, 25 of them in the five years to SEP 2025.
Pharmaceuticals 38Organic fine chemistry 14Measurement 6Biotechnology 1
- Dosing regimens of (S)-1-(4-fluorophenyl)-1-(2-(4-(6-(1-methyl-1H-pyrazol-4-yl)pyrrolo[2,1-f][1,2,4]triazin-4-yl)piperazinyl)-pyrimidin-5-yl)ethan-1-amine for treatment of indolent systemic mastocytosisUS 12,252,494 · granted MAR 18, 2025
- MAP4K1 inhibitorsUS 12,202,844 · granted JAN 21, 2025
- EGFR inhibitorsUS 12,172,983 · granted DEC 24, 2024
- Crystalline forms of (S)-1-(4-fluorophenyl)-1-(2-(4-(6-(1-methyl-1H-pyrazol-4-yl)pyrrolo[2,1-f][1,2,4]triazin-4-yl)piperazinyl)-pyrimidin-5-yl)ethan-1-amine and methods of makingUS 12,060,354 · granted AUG 13, 2024
- MAP4K1 inhibitorsUS 12,042,495 · granted JUL 23, 2024
Newest 5 shown · Granted to Blueprint Medicines Corporation · PatentsView (USPTO), data through SEP 30, 2025 · CC BY 4.0
Their plant
| Facility | City | State | Employees | Status |
|---|---|---|---|---|
| Blueprint Medicines Corporation | Cambridge | MA | — | LIKELY ACTIVE |
Compiled from federal records — EPA, OSHA, SAM.gov and the U.S. Census — and from the company’s own website. Federal source data is public domain. Each plant’s page names the source of every field.
